- Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate) Oral Suspension in the United States
- Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results
- Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million
- Endo to Participate at J.P. Morgan Healthcare Conference
- Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States
- Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference
- Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
- Endo Implements CEO Succession Plan
- Endo Reports Third-Quarter 2019 Financial Results
As of last trade,
Endo International PLC (ENDP:NSQ) traded at 5.86, 197.21% above the 52 week low of 1.97 set on Sep 05, 2019.
1.97Sep 05 201912.49Feb 28 2019
Markit short selling activity
|Market cap||1.28bn USD|
|EPS (TTM)||-1.83 |
Data delayed at least 15 minutes, as of Jan 29 2020 14:41 GMT.